| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3343338
Max Phase: Preclinical
Molecular Formula: C11H14N2O2
Molecular Weight: 206.25
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COCCn1nc2ccccc2c1OC
Standard InChI: InChI=1S/C11H14N2O2/c1-14-8-7-13-11(15-2)9-5-3-4-6-10(9)12-13/h3-6H,7-8H2,1-2H3
Standard InChI Key: AVTOXOLYRSBKLQ-UHFFFAOYSA-N
Associated Targets(Human)
Myeloperoxidase 1002 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 206.25 | Molecular Weight (Monoisotopic): 206.1055 | AlogP: 1.69 | #Rotatable Bonds: 4 |
| Polar Surface Area: 36.28 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 1.46 | CX LogP: 1.66 | CX LogD: 1.66 |
| Aromatic Rings: 2 | Heavy Atoms: 15 | QED Weighted: 0.76 | Np Likeness Score: -1.31 |
References
| 1. Roth A, Ott S, Farber KM, Palazzo TA, Conrad WE, Haddadin MJ, Tantillo DJ, Cross CE, Eiserich JP, Kurth MJ.. (2014) Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones., 22 (22): [PMID:25438766] [10.1016/j.bmc.2014.09.044] |
Source
Source(1):